News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
277,631 Results
Type
Article (8425)
Company Profile (40)
Press Release (269166)
Section
Business (95092)
Career Advice (620)
Deals (17073)
Drug Delivery (12)
Drug Development (25268)
Employer Resources (38)
FDA (4657)
Job Trends (6062)
News (143295)
Policy (9771)
Tag
Academia (779)
Alliances (18327)
Alzheimer's disease (340)
Approvals (4674)
Artificial intelligence (46)
Bankruptcy (107)
Best Places to Work (4536)
Biotechnology (38)
Breast cancer (57)
Cancer (548)
Career advice (532)
Cell therapy (121)
Clinical research (20992)
Collaboration (177)
Compensation (154)
COVID-19 (512)
C-suite (80)
Data (566)
Diabetes (46)
Diagnostics (2559)
Earnings (43700)
Employer resources (37)
Events (51372)
Executive appointments (277)
FDA (4915)
Funding (204)
Gene therapy (50)
GLP-1 (140)
Government (731)
Healthcare (7011)
Infectious disease (528)
Interviews (72)
IPO (8634)
Job creations (1643)
Job search strategy (486)
Layoffs (135)
Legal (2931)
Lung cancer (82)
Manufacturing (61)
Medical device (4941)
Medtech (4942)
Mergers & acquisitions (8633)
Metabolic disorders (127)
Neuroscience (447)
NextGen: Class of 2025 (2356)
Non-profit (1491)
Northern California (1008)
Obesity (63)
Opinion (39)
People (28449)
Phase I (6503)
Phase II (8999)
Phase III (7205)
Pipeline (378)
Postmarket research (805)
Preclinical (2405)
Press Release (66)
Radiopharmaceuticals (124)
Rare diseases (77)
Real estate (2840)
Regulatory (6510)
Research institute (693)
Resumes & cover letters (88)
Series A (37)
Southern California (670)
Startups (1372)
United States (7150)
Vaccines (70)
Date
Last 7 days (217)
Last 30 days (887)
Last 365 days (13144)
2025 (1611)
2024 (13606)
2023 (16197)
2022 (21983)
2021 (23472)
2020 (22282)
2019 (17871)
2018 (13627)
2017 (12485)
2016 (11941)
2015 (15455)
2014 (12091)
2013 (9718)
2012 (10456)
2011 (11257)
2010 (10596)
Location
Africa (261)
Arizona (60)
Asia (14596)
Australia (2149)
California (2005)
Canada (688)
China (83)
Colorado (73)
Connecticut (101)
Europe (29880)
Florida (240)
Illinois (126)
Indiana (77)
Japan (75)
Kansas (60)
Maine (37)
Maryland (203)
Massachusetts (1448)
Michigan (87)
Minnesota (138)
New Jersey (606)
New York (519)
North Carolina (329)
Northern California (1008)
Ohio (51)
Pennsylvania (332)
South America (469)
Southern California (670)
Texas (220)
Utah (133)
Virginia (42)
Washington State (174)
277,631 Results for "cambrex corporation charles city ia".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Cambrex Announces Strategic Agreement with Lilly to Support Biotech Collaborator Manufacturing
December 6, 2024
·
2 min read
Pharm Country
Cambrex Nears Completion of 5-year, $100-Million-Dollar Investment Plan, One Year Ahead of Schedule
Cambrex, a leading global contract development and manufacturing organization, announced that it is nearing the completion of a 5-year, $100-million-dollar investment strategy, one year ahead of schedule.
March 18, 2024
·
2 min read
Press Releases
Cambrex Opens New Stability Storage Facility in Durham, North Carolina
October 17, 2024
·
2 min read
Press Releases
Portal Biotechnologies Announces Over 50 Partnerships and Oversubscribed $7M Seed Round Led by IA Ventures
December 19, 2024
·
3 min read
Press Releases
Charles River Expands Apollo™ Ecosystem, Offering Bespoke Client Experiences
January 21, 2025
·
4 min read
Press Releases
Cambrex Announces New Liquid-Phase Peptide Synthesis Manufacturing Technology
September 19, 2024
·
3 min read
BioCapital
Charles River Laboratories Publishes 2023 Corporate Citizenship Report
Charles River Laboratories International, Inc. announced the publication of its 2023 Corporate Citizenship Report, which includes progress and results from 2022 and 2023.
March 27, 2024
·
5 min read
Press Releases
Ascletis Announces Positive Results from U.S. Phase Ia Single Ascending Dose Study of Small Molecule Oral GLP-1R Agonist ASC30 and Provides Program Update
January 21, 2025
·
6 min read
Press Releases
Preliminary Results of Qilu Pharmaceutical’s Phase Ia Study on GPRC5D/CD3-Targeting Bispecific Antibody QLS32015 Unveiled at 2024 ASH Annual Meeting
December 25, 2024
·
3 min read
Drug Development
Ultragenyx Announces Positive Top-Line Results from Phase 3 Study of DTX401 Gene Therapy for Glycogen Storage Disease Type Ia (GSDIa)
Ultragenyx Pharmaceutical Inc. today announced positive topline results from the Phase 3 GlucoGene study ( NCT05139316 ) evaluating DTX401, an investigational gene therapy for the treatment of patients aged eight years and older with glycogen storage disease type Ia (GSDIa).
May 30, 2024
·
9 min read
1 of 27,764
Next
